Sections
| Title |
|---|
| Slide 1: Executive Summary |
| Introduction |
| Slide 2: Uses of IVD Equipments |
| Slide 3: Segmentation of Product by Size of Equipment |
| Slide 4: Value Chain of IVD |
| Market Overview |
| Slide 5: In Vitro Diagnostics Overview, Market Size and Growth (Value-Wise: 2011 2016e), Market Segmentation (Value-Wise: 2011) |
| Slide 6: In Vitro Diagnostics Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), In Vitro Diagnostics Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 7: Immunochemistry Overview, Market Size and Growth (Value-Wise: 2011 2016e), Market Segmentation (Value-Wise: 2011) |
| Slide 8: Immunochemistry Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Immunochemistry Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 9: Elisa Kits Overview, Market Size and Growth (Value-Wise: 2011 2016e), Rapid Tests Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 10: Biochemistry Overview, Market Size and Growth (Value-Wise: 2011 2016e), Biochemistry Instruments Segmentation (Value-Wise: 2011) |
| Slide 11: Biochemistry Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Biochemistry Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 12: Hematology Overview, Market Size and Growth (Value-Wise: 2011 2016e), Hematology Instruments Segmentation (Value-Wise: 2011) |
| Slide 13: Hematology Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Hematology Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 14: Hematology Geographic Distribution (Value-Wise: 2011) |
| Slide 15: Microbiology Overview, Market Size and Growth (Value-Wise: 2011 2016e), Market Segmentation (Value-Wise: 2011) |
| Slide 16: Microbiology Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Microbiology Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 17: Blood Gas & Electrolyte Overview, Market Size and Growth (Value-Wise: 2011 2016e), Blood Gas & Electrolyte Instruments Segmentation (Value-Wise: 2011) |
| Slide 18: Blood Gas & Electrolyte Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Blood Gas & Electrolyte Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 19: Molecular Diagnostics Overview, Market Size and Growth (Value-Wise: 2011 2016e), Molecular Diagnostics Instruments Segmentation (Value-Wise: 2011) |
| Slide 20: Molecular Diagnostics Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Molecular Diagnostics Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 21: Urinalysis Overview, Market Size and Growth (Value-Wise: 2011 2016e), Urinalysis Instruments Segmentation (Value-Wise: 2011) |
| Slide 22: Urinalysis Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Urinalysis Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Slide 23: Coagulation Analysis Overview, Market Size and Growth (Value-Wise: 2011 2016e), Coagulation Analysis Instruments Segmentation (Units Sold: 2011) |
| Slide 24: Coagulation Analysis Instruments Overview, Market Size and Growth (Value-Wise: 2011 2016e), Coagulation Analysis Reagents Overview, Market Size and Growth (Value-Wise: 2011 2016e) |
| Drivers & Challenges |
| Slide 25: Summary |
| Slide 26-32: Drivers |
| Slide 33-34: Challenges |
| Laws and Guidelines |
| Slide 35: Directives Laid Down by Regulatory Bodies in Europe |
| Slide 36: Directives Laid Down by U.S. FDA |
| Slide 37: Directives Laid Down by Indian Government |
| Slide 38: Association of Diagnostics Manufacturers of India (ADMI) |
| Trends |
| Slide 39: Summary |
| Slide 40: Automation |
| Slide 41: Remote Data Acquisition, Enzyme-Linked Fluorescence Assay (ELFA) |
| Slide 42: Chemiluminescence Immunoassay (CLIA), Capillary Electrophoreses (CE) Based CLIA |
| Slide 43: Electrochemiluminescence Immunoassay (ECLIA) |
| Slide 44: Direct Access Testing, Rapid Accurate Quantification at Point of Care |
| Competition |
| Slide 45: Market Competition Porters Five Forces Analysis |
| Slide 46-51: Major Public Companies (Domestic) |
| Slide 52-65: Major Private Companies (Domestic) |
| Slide 66-89: Major Private Companies (Foreign) |
| Strategic Recommendation |
| Slide 90-91: Key Recommendations |
| Appendix |
| Slide 92: Appendix |
| Slide 93: Sources of Information |